A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease

Jessica S. Calleo, Amber B. Amspoker, Aliya I. Sarwar, Mark E. Kunik, Joseph Jankovic, Laura Marsh, Michele York, Melinda A. Stanley

Research output: Contribution to journalArticle

Abstract

Anxiety and depression often remain unrecognized or inadequately treated in patients with Parkinson disease (PD). Cognitive-behavioral therapy (CBT) is effective, but limited evidence supports its use for anxiety and depression in patients with PD. Sixteen patients with PD having significant anxiety and/or depressive symptoms were assigned to CBT or enhanced usual care. Assessments occurred at baseline, posttreatment, and 1-month follow-up. The CBT intervention included tools for anxiety, depression, and healthy living with PD symptoms. Individual sessions were delivered by telephone or in person, based on patient preference. Treatment was feasible with participants choosing 67% of sessions by telephone and 80% completed treatment. The between-group effect sizes for change scores from baseline to posttreatment and baseline to 1-month follow-up were large (posttreatment: d = 1.49 for depression and 1.44 for anxiety; 1-month follow-up: d =.73 for depression and 1.24 for anxiety), although only the posttreatment effect size for depression was significant. This pilot CBT program is feasible for treatment of anxiety and depression in patients with PD.

Original languageEnglish (US)
Pages (from-to)210-217
Number of pages8
JournalJournal of Geriatric Psychiatry and Neurology
Volume28
Issue number3
DOIs
StatePublished - Sep 24 2015
Externally publishedYes

Fingerprint

Parkinson Disease
Anxiety
Depression
Cognitive Therapy
Therapeutics
Telephone
Patient Preference

Keywords

  • anxiety
  • cognitive-behavioral therapy
  • depression
  • Parkinson disease

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Neurology
  • Geriatrics and Gerontology

Cite this

Calleo, J. S., Amspoker, A. B., Sarwar, A. I., Kunik, M. E., Jankovic, J., Marsh, L., ... Stanley, M. A. (2015). A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease. Journal of Geriatric Psychiatry and Neurology, 28(3), 210-217. https://doi.org/10.1177/0891988715588831

A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease. / Calleo, Jessica S.; Amspoker, Amber B.; Sarwar, Aliya I.; Kunik, Mark E.; Jankovic, Joseph; Marsh, Laura; York, Michele; Stanley, Melinda A.

In: Journal of Geriatric Psychiatry and Neurology, Vol. 28, No. 3, 24.09.2015, p. 210-217.

Research output: Contribution to journalArticle

Calleo, JS, Amspoker, AB, Sarwar, AI, Kunik, ME, Jankovic, J, Marsh, L, York, M & Stanley, MA 2015, 'A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease', Journal of Geriatric Psychiatry and Neurology, vol. 28, no. 3, pp. 210-217. https://doi.org/10.1177/0891988715588831
Calleo, Jessica S. ; Amspoker, Amber B. ; Sarwar, Aliya I. ; Kunik, Mark E. ; Jankovic, Joseph ; Marsh, Laura ; York, Michele ; Stanley, Melinda A. / A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease. In: Journal of Geriatric Psychiatry and Neurology. 2015 ; Vol. 28, No. 3. pp. 210-217.
@article{70c166ae70104726a56def30caa5949e,
title = "A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease",
abstract = "Anxiety and depression often remain unrecognized or inadequately treated in patients with Parkinson disease (PD). Cognitive-behavioral therapy (CBT) is effective, but limited evidence supports its use for anxiety and depression in patients with PD. Sixteen patients with PD having significant anxiety and/or depressive symptoms were assigned to CBT or enhanced usual care. Assessments occurred at baseline, posttreatment, and 1-month follow-up. The CBT intervention included tools for anxiety, depression, and healthy living with PD symptoms. Individual sessions were delivered by telephone or in person, based on patient preference. Treatment was feasible with participants choosing 67{\%} of sessions by telephone and 80{\%} completed treatment. The between-group effect sizes for change scores from baseline to posttreatment and baseline to 1-month follow-up were large (posttreatment: d = 1.49 for depression and 1.44 for anxiety; 1-month follow-up: d =.73 for depression and 1.24 for anxiety), although only the posttreatment effect size for depression was significant. This pilot CBT program is feasible for treatment of anxiety and depression in patients with PD.",
keywords = "anxiety, cognitive-behavioral therapy, depression, Parkinson disease",
author = "Calleo, {Jessica S.} and Amspoker, {Amber B.} and Sarwar, {Aliya I.} and Kunik, {Mark E.} and Joseph Jankovic and Laura Marsh and Michele York and Stanley, {Melinda A.}",
year = "2015",
month = "9",
day = "24",
doi = "10.1177/0891988715588831",
language = "English (US)",
volume = "28",
pages = "210--217",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients with Parkinson Disease

AU - Calleo, Jessica S.

AU - Amspoker, Amber B.

AU - Sarwar, Aliya I.

AU - Kunik, Mark E.

AU - Jankovic, Joseph

AU - Marsh, Laura

AU - York, Michele

AU - Stanley, Melinda A.

PY - 2015/9/24

Y1 - 2015/9/24

N2 - Anxiety and depression often remain unrecognized or inadequately treated in patients with Parkinson disease (PD). Cognitive-behavioral therapy (CBT) is effective, but limited evidence supports its use for anxiety and depression in patients with PD. Sixteen patients with PD having significant anxiety and/or depressive symptoms were assigned to CBT or enhanced usual care. Assessments occurred at baseline, posttreatment, and 1-month follow-up. The CBT intervention included tools for anxiety, depression, and healthy living with PD symptoms. Individual sessions were delivered by telephone or in person, based on patient preference. Treatment was feasible with participants choosing 67% of sessions by telephone and 80% completed treatment. The between-group effect sizes for change scores from baseline to posttreatment and baseline to 1-month follow-up were large (posttreatment: d = 1.49 for depression and 1.44 for anxiety; 1-month follow-up: d =.73 for depression and 1.24 for anxiety), although only the posttreatment effect size for depression was significant. This pilot CBT program is feasible for treatment of anxiety and depression in patients with PD.

AB - Anxiety and depression often remain unrecognized or inadequately treated in patients with Parkinson disease (PD). Cognitive-behavioral therapy (CBT) is effective, but limited evidence supports its use for anxiety and depression in patients with PD. Sixteen patients with PD having significant anxiety and/or depressive symptoms were assigned to CBT or enhanced usual care. Assessments occurred at baseline, posttreatment, and 1-month follow-up. The CBT intervention included tools for anxiety, depression, and healthy living with PD symptoms. Individual sessions were delivered by telephone or in person, based on patient preference. Treatment was feasible with participants choosing 67% of sessions by telephone and 80% completed treatment. The between-group effect sizes for change scores from baseline to posttreatment and baseline to 1-month follow-up were large (posttreatment: d = 1.49 for depression and 1.44 for anxiety; 1-month follow-up: d =.73 for depression and 1.24 for anxiety), although only the posttreatment effect size for depression was significant. This pilot CBT program is feasible for treatment of anxiety and depression in patients with PD.

KW - anxiety

KW - cognitive-behavioral therapy

KW - depression

KW - Parkinson disease

UR - http://www.scopus.com/inward/record.url?scp=84940179714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940179714&partnerID=8YFLogxK

U2 - 10.1177/0891988715588831

DO - 10.1177/0891988715588831

M3 - Article

VL - 28

SP - 210

EP - 217

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 3

ER -